Challenges in Treating Bundibugyo Virus in the Democratic Republic of Congo

In the town of Mongbwalu, Democratic Republic of Congo, health workers collect medication for patients suspected of having Bundibugyo virus. The current outbreak has exposed the urgent need for effective treatments.

Researchers are testing several drugs that showed promise in early studies against this virus. This marks a critical step, as the outbreak has affected at least 695 people, with 138 fatalities reported.

Dr. Papys Lame oversees operations at an Ebola treatment center in Rwampara. Here, medical staff focus on rehydrating patients, providing transfusions, and offering respiratory support. Patients battle severe symptoms such as diarrhea, vomiting, and uncontrolled bleeding.

Compared to previous outbreaks, there has been some progress. More treatment options allow better patient outcomes, according to Dr. Lame. However, a targeted treatment for the Bundibugyo virus remains absent.

Most Ebola disease outbreaks over the last five decades were due to a different strain, known as the Ebola virus. The World Health Organization has recommended treatments for this strain based on clinical trials. These treatments, however, do not necessarily work against Bundibugyo due to significant evolutionary differences between the viruses.

The search for effective treatments continues, as researchers strive to tackle this particular viral threat.